Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

NCT02034968 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No recruitment

Conditions

Stage IV Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Nimotuzumab

Sponsor

Zhejiang University